On December 8, ÐÜèÊÓƵsubmitted comments to the Federal Trade Commission (FTC) for the official record of an FTC workshop held in early November on ways to promote greater competition in prescription drug markets—as a way to both reduce costs and improve access to drugs and treatments.
Resources
ÐÜèÊÓƵComment Letter to FTC on Competition in Prescription Drug Markets
Comment Letter
Document Info
Published on Dec 8, 2017
Download and read the full Resource.
- Related Issues
- High-Price Drugs